RE: The most important potential is being missed here21 Jul 2022 14:17
The sad part is that another "just over the next hill" RNS on Paraytec has diverted everyone back to dreams of riches.
The odds are stacked that another placing is coming now they have overturned the NO vote from earlier in the year, this RNS is an attempt to excite the punters, and of course it's worked on here.
The SP might be affected by COVID hype, but the balance sheet and revenue value here remains Phasefocus.....
Paraytec is a looooooong way away from being commercial because that relies on more testing, production, getting the CE mark, and then being good for other uses like sepsis and bladder cancer applications (this is stated in the RNS if you read it).